Haemonetics Corp. (HAE)

Haemonetics (HAE) Financial Statements


Haemonetics Financial Overview

Haemonetics's market cap is currently ―. The company's EPS TTM is $2.245; its P/E ratio is 37.06; Haemonetics is scheduled to report earnings on August 8, 2023, and the estimated EPS forecast is $0.73. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 305.30M$ 297.49M$ 261.46M$ 265.00M$ 259.77M
Gross Profit$ 158.71M$ 157.88M$ 142.26M$ 136.31M$ 138.56M
EBIT$ 42.22M$ 46.73M$ 30.77M$ 19.20M$ 35.65M
EBITDA$ 50.30M$ 70.17M$ 53.21M$ 44.01M$ 60.02M
Net Income Common Stockholders$ 32.92M$ 33.20M$ 19.88M$ 9.74M$ 23.23M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 224.00M$ 241.20M$ 214.95M$ 259.50M$ 236.88M
Total Assets$ 1.88B$ 1.87B$ 1.82B$ 1.86B$ 1.83B
Total Debt$ 766.77M$ 817.75M$ 769.99M$ 780.78M$ 777.18M
Net Debt$ 542.77M$ 576.55M$ 555.05M$ 521.29M$ 540.30M
Total Liabilities$ 1.10B$ 1.14B$ 1.05B$ 1.11B$ 1.10B
Stockholders Equity$ 775.98M$ 729.01M$ 770.42M$ 749.42M$ 730.77M
Cash Flow-
Free Cash Flow$ 44.76M$ 51.08M$ -3.47M$ 32.94M$ 35.77M
Operating Cash Flow$ 61.45M$ 87.04M$ 41.99M$ 68.05M$ 62.43M
Investing Cash Flow$ -36.00M$ -31.07M$ -58.21M$ -34.51M$ -15.46M
Financing Cash Flow$ -47.22M$ -25.69M$ -23.39M$ -8.77M$ -2.04M
Currency in USD

Haemonetics Earnings and Revenue History

Haemonetics Debt to Assets

Haemonetics Cash Flow

Haemonetics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis